Karyopharm Therapeut
(KPTI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 47 | 48 | 59 | 0 | 25 |
| Gross Profit | 47 | 48 | 59 | N/A | 25 |
| Operating Expenses | 27,212 | 25,790 | 30,535 | 27,349 | 29,328 |
| Operating Income | -27,165 | -25,742 | -30,476 | -27,349 | -29,303 |
| Other Income | 369 | 317 | 318 | 290 | 257 |
| Pre-tax Income | -26,796 | -25,425 | -30,158 | -27,059 | -29,046 |
| Net Income Continuous | -26,935 | -25,425 | -30,158 | -27,059 | -29,046 |
| Net Income | $-26,935 | $-25,425 | $-30,158 | $-27,059 | $-29,046 |
| EPS Basic Total Ops | -9.60 | -10.34 | -12.59 | -11.24 | -12.14 |
| EPS Basic Continuous Ops | -9.55 | -10.35 | -12.57 | -11.31 | -12.19 |
| EPS Diluted Total Ops | -9.60 | -10.34 | -12.59 | -11.24 | -12.14 |
| EPS Diluted Continuous Ops | -9.55 | -10.35 | -12.57 | -11.31 | -12.19 |
| EBITDA(a) | $-26,625 | $-25,319 | $-30,016 | $-26,856 | $-28,691 |